![33964148_28_10_2022_2 [Converted]-01-01.png](https://static.wixstatic.com/media/6ef6c7_5f544a22d3e44e38864a07b9d0a57a38~mv2.png/v1/fill/w_980,h_102,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/6ef6c7_5f544a22d3e44e38864a07b9d0a57a38~mv2.png)
Technology
Our Products
Critical Innovations is developing this patented technology through two separate US Army Medical Research & Development Command (USAMRDC..
The Defense Health Agency (DHA) is funding this patented technology through a Phase II SBIR award. The Donaldson Decompression Needle™..
_JPG.jpg)
Critical Innovations is developing this patent-pending technology via funding from the US Army Medical Materiel Development Activity
Recipient of the MTEC 2020 Prototype of the Year Award, this program is funded by the U.S. Army Medical Materiel Development Activity (USAMMDA)..
Critical Innovations is developing this exciting, patent-pending technology through Defense Health Agency (DHA) Phase IIE SBIR funding...
Under a previous Phase I SBIR award and under current Phase II SBIR funding from the US Army, Critical Innovations is currently developing Succor™...
Previously funded under a Defense Health Agency (DHA) Direct-to-Phase II SBIR award, and currently funded under both DHA Phase IIE...
Funded by the JPC-2/Military Infectious Diseases Research Program through an Other Transaction Agreement with Military Technology...
Previously funded under a Chemical and Biological Defense Program (CBDP) Phase I SBIR award and currently under CBDP Phase II SBIR funding...
Under Defense Health Agency (DHA) Phase I and Phase II SBIR funding, as well as funding from JPC-2/MIDRP via MTEC, Critical Innovations..
Under US Space Force Direct-to-Phase II SBIR funding, Critical Innovations is developing the Fully-Qualified Manufacturing™ (FQM™) system...
- CAUTION -
All medical technologies listed on this page are INVESTIGATIONAL and NOT AVAILABLE FOR COMMERCIAL SALE. These statements have NOT been evaluated by the Food and Drug Administration and these technologies are NOT currently approved for human use.
CD010 Rev.K 2023-09-15